Financial statements Max-Pharma

Cash flow statement of Max-Pharma

Company age:
Age:
9 y. 8 m. 30 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Cash flow Profitability

Cash inflows of MAX-PHARMA

Year
2018
2019
2020
2021
2022
2023
Net cash from operating expenses -5 083 606,42 2 961 658,29 1 849 928,48 6 067 128,27 4 626 143,85 -2 219 172,02
Net cash flow from investing activities 1 089 162,75 -118 507,12 -565 497,17 -451 633,94 -651 288,47 -2 695 245,06
Net cash flow from financial activities 4 038 124,89 -3 063 900,47 -1 357 722,48 -5 542 976,55 -3 716 840,66 4 832 641,58
Total net cash flow 43 681,22 -220 749,30 -73 291,17 72 517,78 258 014,72 -81 775,50
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.